SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : ISOMAN AND HIS CAVE OF SOLITUDE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ISOMAN who wrote ()1/22/1999 7:21:00 AM
From: ISOMAN   of 539
 
Hope

As I ate breakfast one morning, I overheard two
oncologists conversing. One complained bitterly, "You know,
Bob, I just don't understand it. We used the same drugs, the
same dosage, the same schedule and the same entry criteria.
Yet I got a 22 percent response rate and you got a 74
percent. That's unheard of for metastatic cancer. How do you
do it?"
His colleague replied, "We're both using Etoposide,
Platinum, Oncovin and Hydroxyurea. You call yours EPOH. I
tell my patients I'm giving them HOPE. As dismal as the
statistics are, I emphasize that we have a chance."

By William M. Buchholz, M.D.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News